KRKA - Access to the ESPI system (1/2012)

KRKA - Access to the ESPI system (1/2012)

10.04.2012 11:26

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 1 / 2012
Date of issue: 2012-04-10
Short name of the issuer
KRKA
Subject
Access to the ESPI system
Official market - legal basis
Inne uregulowania
Unofficial market - legal basis
Contents of the report:
The Management Board of Krka, tovarna zdravil, d.d., Novo mesto (the "Company") hereby informs that on 10 April 2012 the Company obtained access to the Electronic System for Information Transmission (Elektroniczny System Przekazywania Informacji - ESPI). Starting from 10 April 2012, the Company will provide its current and periodical information through ESPI in addition to complying with its reporting obligations through the Slovenian electronic system for the dissemination of the regulated information, SEOnet. Legal basis: § 11.1 of the Rules of using the Electronic System for Information Transmission.
Annexes
File Description

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

| | | KRKA, TOVARNA ZDRAVIL D.D. | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | | (fullname of the issuer) | | | | | |
| | | KRKA | | Farmaceutyczny (far) | | | |
| | | (short name of the issuer) | | (sector according to clasification of the WSE in Warsow) | | | |
| | | 8501 | | Nove Mesto | | | |
| | | (post code) | | (city) | | | |
| | | Smarjeska | | 6 | | | |
| | | (street) | | (number) | | | |
| | | +386 7 331 21 11 | | +386 7 332 15 37 | | | |
| | | (phone number) | | | (fax) | | |
| | | (e-mail) | | | (web site) | | |
| | | nie dotyczy | | | | | |
| | | (NIP)
| | | (REGON) | | |

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-04-10 Jože Colarič President of the Management Board and Chief Executive

REPORT
INFORMATION ABOUT THE ENTITY
SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Wybrane dla Ciebie
Komentarze (0)